What are the contraindications for the fecal immunochemical test (FIT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FIT Test Contraindications

The FIT test has no absolute contraindications for its intended use as a colorectal cancer screening tool in asymptomatic, average-risk individuals, but it should NOT be used in symptomatic patients, those with recent colonoscopy, or in acute care settings (ED/inpatient). 1, 2

When FIT Should NOT Be Used

Inappropriate Clinical Settings

  • Symptomatic patients: FIT is contraindicated in patients with GI symptoms (rectal bleeding, diarrhea, weakness, abdominal pain). These patients require direct diagnostic evaluation, not screening tests 2
  • Emergency department or inpatient settings: Studies demonstrate 100% inappropriate use when ordered in acute care settings, leading to unnecessary interventions and prolonged hospitalizations 2
  • Recent colonoscopy: FIT should not be performed within 5 years of a colonoscopy with adequate bowel preparation 3. Among veterans who had both procedures, 88% of FIT tests following colonoscopy were judged inappropriate 3

Patient-Related Factors

While the 2017 Multi-Society Task Force guidelines 1 do not list specific patient contraindications, the following situations make FIT inappropriate:

  • Active upper or lower GI bleeding: Symptomatic bleeding requires diagnostic workup, not screening
  • Known colorectal pathology: Patients with established inflammatory bowel disease, known polyps, or previous CRC need surveillance colonoscopy, not FIT
  • High comorbidity burden: Recent data shows 54.4% of FIT-positive patients were ineligible for follow-up procedures due to contraindications related to severe comorbidities 4

Critical Implementation Caveats

No Dietary or Medication Restrictions Required

The Task Force strongly recommends that patients NOT adjust diet or medications to complete FIT 1. This is a common pitfall—unlike older guaiac-based tests, FIT does not require:

  • Avoiding red meat
  • Stopping NSAIDs or anticoagulants (though anticoagulants are associated with positive results 2)
  • Dietary modifications

Sample Collection Requirements

  • Use spontaneously passed stool specimens only—NOT digital rectal examination samples 1
  • Programs need not adjust distribution based on ambient temperature 1

The Positive FIT Mandate

When FIT is positive, colonoscopy is the ONLY recommended follow-up test (strong recommendation, moderate evidence) 1. This is non-negotiable:

  • 27.5% of veterans with positive FIT failed to complete colonoscopy within one year 3
  • Positive predictive value for CRC ranges from 0.9% at low hemoglobin levels (20-39.9 μg/g) to 6.7% at ≥200 μg/g 5
  • All positive FIT results require colonoscopy regardless of quantitative value, as neoplastic findings occur across the entire spectrum 5

Common Pitfalls to Avoid

  1. Ordering FIT in symptomatic patients: This is the most common misuse—negative FIT may falsely reassure clinicians about worrisome symptoms requiring investigation 2

  2. Failing to ensure annual repeat testing: After negative FIT, only 62.4% of eligible patients underwent repeat testing as recommended 3

  3. Using FIT too soon after colonoscopy: This represents 1.6% of all FITs performed but 88% were inappropriate 3

  4. Ordering upper GI evaluation for positive FIT with negative colonoscopy: In the absence of upper GI symptoms, this is not recommended 1

Related Questions

If a patient had a positive fecal immunochemical test (FIT) while menstruating and a subsequent repeat FIT is negative, should a colonoscopy still be performed?
In a 65-year-old man under surveillance after T1 rectosigmoid carcinoma resected by endoscopic full-thickness resection, who had a 10 mm Kudo 3L polyp removed from the scar margin with an incompletely cleared edge and now has a positive fecal immunochemical test, is a colonoscopy scheduled in five years sufficient or should it be performed earlier because of the wound margin?
What are the indications, recommended frequency, and follow‑up steps for a fecal immunochemical test (FIT) in average‑risk adults aged 50–75?
Can internal hemorrhoids cause a positive fecal immunochemical test (FIT)?
In average‑risk adults aged 45–75, how should a fecal occult blood test be performed and interpreted for colorectal cancer screening?
What are the classification categories for hypertension based on blood pressure readings?
How should increased drowsiness be managed in a client who started Invega (paliperidone) 6 mg and Lamictal (lamotrigine) 25 mg?
Can a 22-year-old experience a psychotic break with recurrent annual episodes of psychosis?
What is the appropriate letrozole dosing regimen for ovulation induction in patients with polycystic ovary syndrome (PCOS)?
How should blood glucose be monitored and insulin dosing adjusted in an insulin‑dependent diabetic patient receiving weekly 300 mg fluconazole for onychomycosis?
How should I urgently evaluate and manage a 72-year-old patient with new severe progressive shooting pain involving the shoulders, chest, and back, now unable to walk, and a close relative recently diagnosed with multiple myeloma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.